人妻无码一区二区不卡无码av,国产精品久久久久久妇女,国产亚洲一区二区手机在线观看,国产老熟妇精品观看

In order to solemnly commemorate the 100th anniversary of the founding of the Communist Party of China and further strengthen the construction of the team of party members, Leadingpharm launched the theme activity of "reviewing the history of the party for 100 years and inheriting the ‘red gene’" to celebrate the 100th anniversary of the founding of the party on the afternoon of June 30.

On June 19th, Zhengzhou Pairui (Small Molecule API and Preparation CDMO Platform) was officially inaugurated by Beijing Leadingpharm, Beijing Chempion Pharmaceuticals and Lifezhengzhou. As an important part of Lifezhengzhou-Leadingpharm CXO Integrated Service System, Pairui will become an important part of promoting the high-quality development of small molecular preparation industrialization technical services in Zhengzhou Airport Experimental Zone.

On the occasion of the 100th anniversary of the founding of the Communist Party of China, in response to the call of General Secretary Xi Jinping, on June 9, representatives of party members from Beijing Leadingpharm, Beijing Normal University School of Chemistry, Lanzhou University School of Chemistry and Chemical Engineering, and Shanghai Yanyuan Pharmaceuticals gathered at Beijing Normal University to jointly carry out a seminar on "learning the history of the Party and promoting development" to deepen the Party's construction and promote the construction of industry, education and research.

On the morning of May 27th, the signing ceremony of strategic cooperation between Leadingpharm, Liansheng Pharmaceutical and Logan Instruments was successfully held.

Jiangsu spectrum new biomedical co. , Ltd. , Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd , Germany Meltenyi biological technology co. , LTD. and Beijing Leadingpharm formally signed a strategic cooperation agreement to build the CXO Solution of pharmaceutical, non - clinical research, clinical research, equipment and reagent consumables in the field of cell and gene therapy.